ETF Holdings Breakdown of 300765.SZ

Stock NameCSPC Innovation Pharmaceutical Co., Ltd.
Ticker300765.SZ(CNY) Shenzhen Stock Exchange
TYPEEquity
CountryChina

300765.SZ institutional holdings

The following institutional investment holdings of 300765.SZ have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BKM4GZ66 (iShares Core MSCI EM IMI UCITS ETF USD (Acc)) 282,640CNY 1,525,662 1.6%
2025-05-08 IE00BD45KH83 (iShares Core MSCI EM IMI UCITS ETF USD (Dist) GBP) 282,640CNY 1,525,662 1.6%
2025-05-08 IE00BHZPJ239 (iShares MSCI EM ESG Enhanced UCITS ETF USD Acc) 58,460CNY 315,561
2025-05-08 IE00BHZPJ122 (iShares MSCI EM ESG Enhanced UCITS ETF USD Inc GBP) 58,460 0.3%CNY 315,561 1.9%
2025-05-08 IE00B0M63177 (iShares MSCI EM UCITS ETF USD (Dist) USD) 55,020CNY 296,992 1.6%
2025-05-08 IE00BFNM3N12 (iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)) 52,700CNY 284,469
2025-05-08 IE00BFNM3P36 (iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc) GBP) 52,700CNY 284,469
2025-05-08 IE00BQT3WG13 (iShares MSCI China A UCITS USD) 612,073CNY 3,303,909 1.6%
2025-05-08 IE00099GAJC6 (iShares MSCI China A UCITS ETF EUR Hedged (Acc)) 612,073CNY 3,303,909
2025-05-08 IE00BJ5JPG56 (iShares MSCI China UCITS ETF USD Acc) 139,920CNY 755,274
2025-05-08 IE00BL977C92 (iShares MSCI China UCITS ETF) 139,920CNY 755,274
2024-11-12 IE00BKVL7885 (iShares Edge MSCI EM Minimum Volatility ESG UCITS ETF USD (Acc)) 2,400CNY 9,133
Total =2,349,006 CNY 12,675,875
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.